XJB-5-131
XJB-5-131 is a synthetic mitochondria-targeted antioxidant designed to combat oxidative stress. It is a member of the JP4-039 family of compounds, which are known for their ability to protect cells from damage caused by free radicals. XJB-5-131 has been studied for its potential applications in the treatment of various diseases, including neurodegenerative diseases, cancer, and ischemia-reperfusion injury.
Structure and Mechanism[edit | edit source]
XJB-5-131 is a lipophilic cation that is selectively taken up by mitochondria due to the organelle's negative membrane potential. Once inside the mitochondria, XJB-5-131 acts as a free radical scavenger, neutralizing harmful reactive oxygen species (ROS) and preventing oxidative damage to mitochondrial components.
Therapeutic Potential[edit | edit source]
Neurodegenerative Diseases[edit | edit source]
XJB-5-131 has shown promise in preclinical studies for the treatment of neurodegenerative diseases. In models of Parkinson's disease, it has been found to protect dopaminergic neurons from degeneration. Similarly, in models of Huntington's disease, XJB-5-131 has been shown to reduce neuronal death and improve motor function.
Cancer[edit | edit source]
In cancer research, XJB-5-131 has been studied for its potential to protect healthy cells from the toxic effects of radiation therapy. It has been found to selectively protect non-cancerous cells, while leaving cancer cells vulnerable to radiation damage.
Ischemia-Reperfusion Injury[edit | edit source]
XJB-5-131 has also been investigated for its potential to mitigate ischemia-reperfusion injury, a type of tissue damage caused by the restoration of blood supply after a period of ischemia. In animal models, it has been shown to reduce tissue damage and improve survival rates.
Safety and Tolerability[edit | edit source]
In preclinical studies, XJB-5-131 has been found to be well-tolerated with no significant adverse effects reported. However, further studies are needed to fully assess its safety profile in humans.
See Also[edit | edit source]
- JP4-039
- Mitochondria-targeted antioxidants
- Oxidative stress
- Neurodegenerative diseases
- Cancer
- Ischemia-reperfusion injury
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
